Holen Sie sich die Stockscreener-App
3.05
8.13%
-0.27
Schlusskurs vom Vortag:
$3.32
Offen:
$3.38
24-Stunden-Volumen:
42,455
Relative Volume:
1.40
Marktkapitalisierung:
$25.44M
Einnahmen:
$7.50M
Nettoeinkommen (Verlust:
$-9.85M
KGV:
-2.2061
EPS:
-1.3825
Netto-Cashflow:
$-24.56M
1W Leistung:
-15.51%
1M Leistung:
-25.43%
6M Leistung:
-46.96%
1J Leistung:
+40.55%
1-Tages-Spanne:
$3.05
$3.405
1-Wochen-Bereich:
$3.05
$3.90
52-Wochen-Spanne:
$2.19
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
3.05 | 25.44M | 7.50M | -9.85M | -24.56M | -1.3825 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Maxim Group | Buy |
| 2024-04-02 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Eingeleitet | H.C. Wainwright | Buy |
Evaxion A S Adr Aktie (EVAX) Neueste Nachrichten
European ADRs Edged Higher As Biotech Led Friday’s Moves - Finimize
Evaxion receives Prix Galien UK Award for Best digital health solution - GlobeNewswire Inc.
European ADRs Started The Week In The Green - Finimize
European ADRs Edged Higher In US Trading - Finimize
Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints - TipRanks
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech Reports Strong Q3 2025 Results - TipRanks
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade
Evaxion A/S: Shareholders Board Members Managers and Company Profile | US29970R3030 - marketscreener.com
Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - nasdaq.com
Finanzdaten der Evaxion A S Adr-Aktie (EVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):